16 February 2011 - Biotica extends license to Amyris for polyketide engineering technology
Biotica extends license to Amyris for polyketide engineering technology
04 January 2011 - Humboldt Prize awarded to Biotica founder Professor Peter Leadlay
Humboldt Prize awarded to Biotica founder Professor Peter Leadlay
27 September 2010 - Biotica scientists report unique molecular target of bioengineered borrelidin analogues
Study provides further evidence that polyketides address targets inaccessible to small molecules
08 July 2010 - Biotica consolidates leadership in polyketide therapeutics and extends platform
Biotica has acquired polyketide engineering IP originating from Stanford and Harvard Universities and from Kosan Pharmaceuticals.
06 April 2010 - Biotica achieves preclinical proof-of-concept in its nPT-CyP hepatitis C programme
Biotica's cyclophilin inhibitor programme for the treatment of hepatitis C virus, has reached preclinical proof of concept.
Biotica extends license to Amyris for polyketide engineering technology
04 January 2011 - Humboldt Prize awarded to Biotica founder Professor Peter Leadlay
Humboldt Prize awarded to Biotica founder Professor Peter Leadlay
27 September 2010 - Biotica scientists report unique molecular target of bioengineered borrelidin analogues
Study provides further evidence that polyketides address targets inaccessible to small molecules
08 July 2010 - Biotica consolidates leadership in polyketide therapeutics and extends platform
Biotica has acquired polyketide engineering IP originating from Stanford and Harvard Universities and from Kosan Pharmaceuticals.
06 April 2010 - Biotica achieves preclinical proof-of-concept in its nPT-CyP hepatitis C programme
Biotica's cyclophilin inhibitor programme for the treatment of hepatitis C virus, has reached preclinical proof of concept.